posted on 2013-11-08, 00:00authored byOrly Lazarov, Michael P. Demars
Recent intriguing evidence suggests that metabolites of amyloid precursor protein(APP), mutated in familial forms of Alzheimer’s disease(AD), play critical roles indevelopmental and post natal neurogenesis. Of note is soluble APPα (sAPPα) that regulates neural progenitor cell proliferation. The APP family encompasses a group of ubiquitously expressed and evolutionarily conserved, type I transmembrane glycoproteins, whose functions have yet to be fully elucidated. APP can undergo proteolytic cleavage by mutually exclusive pathways. The subtle structural differences between metabolites generated in the different pathways, as well as thei requilibrium, maybe crucial for neuronal function. The implications of this newbody of evidence are significant. Miscleavage of APP would readily impact developmental and postnatal neurogenesis, which might contribute to cognitive deficits characterizing Alzheimer’s disease. This review will discuss the implications of the role of the APP family in neurogenes is for neuronal development, cognitive function, and brain disorders that compromise learning and memory, such as AD.
Funding
The work was supported by the NIA AG033570 (Orly Lazarov), Alzheimer’s Association Young Investigator Award (Orly Lazarov), the Illinois Department of Public Health ADRF award (Orly Lazarov),and the Brain Research Foundation (Orly Lazarov).
History
Publisher Statement
This Document is Protected by copyright and was first published by Frontiers. All rights reserved. It is reproduced with permission.